Elevate Logo
Pricing Contact
Book A Consultation

Skin cancer

Skin cancer

Not all skin cancers are the same. The 3 most common types include basal cell carcinoma, sqaumous cell carcinoma, and melanoma. When dealing with skin cancer, the absolute first priority is your health and the complete removal of the disease. However, because skin cancers frequently occur in highly visible areas like the face, nose, ears, and neck, the resulting scar is a major concern. As plastic surgeons, we are experts in not only completely excising the skin cancer, but meticulously reconstructing the tissue left behind. Our goal is to ensure you are safely cancer-free while preserving your natural appearance and minimizing visible scarring.

/02

Before & After Photos

Patient 01 Before Angle 1 Before Before
Patient 01 After Angle 1 After After
Patient 01

Patient Number

142039

Description

Timeline Timeline Surgeon Surgeon
Patient 02 Before Angle 1 Before Before
Patient 02 After Angle 1 After After
Patient 02

Patient Number

142040

Description

Timeline Timeline Surgeon Surgeon
Patient 03 Before Angle 1 Before Before
Patient 03 After Angle 1 After After
Patient 03

Patient Number

142041

Description

Timeline Timeline Surgeon Surgeon
Patient 04 Before Angle 1 Before Before
Patient 04 After Angle 1 After After
Patient 04

Patient Number

142042

Description

Timeline Timeline Surgeon Surgeon

/03

What to expect

Before surgery consultation Pre-op

Before Surgery

Click here to learn more about what to expect during consultation.

Surgical procedure preparation Procedure

On the Day of Surgery

Click here to learn what to expect on the day of your operation.

Post-operative recovery Post-op

After Surgery

Click here to learn what to expect with your recovery and long-term results.

/04 Support

Frequently Asked Questions.

Can't find what you're looking for? Our support team is here to help you get the most out of Elevate Plastic Surgery.

For many skin cancers on the body or limbs, Dr. Mahoney and Dr. Yeung will personally excise (remove) the cancer along with a safety margin of healthy tissue, and seamlessly reconstruct the area in a single visit. For complex or high-risk cancers on the face, nose, or ears, you may be referred to a Mohs Dermatologist, who removes the cancer layer by layer until you are 100% cancer-free and then reconstructs thereafter.

If a large amount of tissue must be removed to clear the cancer, we cannot simply pull the wound edges together. We must reconstruct the area using either a local flap or skin graft. A local flap uses adjacent, healthy skin and slides or rotates it over the defect, whereas a skin graft involves taking a thin patch of skin from a hidden donor site (like behind the ear or the collarbone) and use it to "patch" the defect.

Almost never. Skin cancer excision and reconstruction are safely, comfortably, and routinely performed under local anesthesia. We will carefully numb the area so you feel absolutely no pain—only slight pressure. You will be awake and relaxed, meaning you avoid the grogginess of general anesthesia and can go home immediately after the procedure.

If we perform a standard excision, the tissue is sent to a specialized laboratory to be examined under a microscope. It typically takes 3-4 weeks for the final pathology report to confirm that the "margins are clear" (meaning 100% of the cancer was successfully removed).

If the initial pathology report shows that microscopic cancer cells reach the very edge of the removed tissue (a "positive margin"), we will simply remove a little bit more tissue to ensure your absolute safety. Once clear margins are achieved, true recurrences in the exact same surgical spot are quite rare, though you will need regular, lifelong skin checks with your dermatologist to monitor for new spots.

Journal Articles

The Evidence

Want to learn more? Drs. Mahoney and Yeung use the latest evidence-based practices to guide their care and achieve the best possible outcomes.

/05

References

01 Guidelines

Schmults CD, Blitzblau R, Aasi SZ, Alam M, Andersen JS, Baumann BC, Bordeaux J, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Grekin RC, Harms K, Ho AL, Holder A, Lukens JN, Medina T, Nehal KS, Nghiem P, Park S, Patel T, Puzanov I, Scott J, Sekulic A, Shaha AR, Srivastava D, Stebbins W, Thomas V, Xu YG, McCullough B, Dwyer MA, Nguyen MQ. NCCN Guidelines® Insights: Squamous Cell Skin Cancer, Version 1.2022. J Natl Compr Canc Netw. 2021 Dec;19(12):1382-1394. doi: 10.6004/jnccn.2021.0059. PMID: 34902824.

02 Guidelines

Schmults CD, Blitzblau R, Aasi SZ, Alam M, Amini A, Bibee K, Bordeaux J, Chen PL, Contreras CM, DiMaio D, Donigan JM, Farma JM, Ghosh K, Harms K, Ho AL, Lukens JN, Mark L, Medina T, Nehal KS, Nghiem P, Olino K, Park S, Patel T, Puzanov I, Rich J, Sekulic A, Shaha AR, Srivastava D, Thomas V, Tomblinson C, Venkat P, Xu YG, Yu S, Yusuf M, McCullough B, Espinosa S. Basal Cell Skin Cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Nov;21(11):1181-1203. doi: 10.6004/jnccn.2023.0056. PMID: 37935106.

03 Guidelines

Swetter SM, Johnson D, Albertini MR, Barker CA, Bateni S, Baumgartner J, Bhatia S, Bichakjian C, Boland G, Chandra S, Chmielowski B, DiMaio D, Dronca R, Fields RC, Fleming MD, Galan A, Guild S, Hyngstrom J, Karakousis G, Kendra K, Kiuru M, Lange JR, Lanning R, Logan T, Olson D, Olszanski AJ, Ott PA, Ross MI, Rothermel L, Salama AK, Sharma R, Skitzki J, Smith E, Tsai K, Wuthrick E, Xing Y, McMillian N, Espinosa S. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2024. J Natl Compr Canc Netw. 2024 Jul;22(5):290-298. doi: 10.6004/jnccn.2024.0036. PMID: 39019054.